Connection

Robert Adams to Child, Preschool

Back to Details
This is a "connection" page, showing publications Robert Adams has written about Child, Preschool.
Robert Adams
Connection Strength
1.539
Child, Preschool
  1. Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1062-e1068.
    View in: PubMed
    Score: 0.119
  2. Transcranial doppler re-screening of subjects who participated in STOP and STOP II. Am J Hematol. 2016 12; 91(12):1191-1194.
    View in: PubMed
    Score: 0.084
  3. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016 Feb 13; 387(10019):661-670.
    View in: PubMed
    Score: 0.079
  4. Toward a stroke-free childhood in sickle cell disease: the 2013 Sherman Lecture. Stroke. 2013 Oct; 44(10):2930-4.
    View in: PubMed
    Score: 0.068
  5. Trends in comorbid sickle cell disease among stroke patients. J Neurol Sci. 2012 Feb 15; 313(1-2):86-91.
    View in: PubMed
    Score: 0.059
  6. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology. 2010 Feb 16; 74(7):588-93.
    View in: PubMed
    Score: 0.053
  7. Influence of age on racial disparities in stroke admission rates, hospital charges, and outcomes in South Carolina. Stroke. 2009 Sep; 40(9):3096-101.
    View in: PubMed
    Score: 0.050
  8. Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell disease. Pediatr Blood Cancer. 2007 Sep; 49(3):318-22.
    View in: PubMed
    Score: 0.045
  9. Trials in sickle cell disease. Pediatr Neurol. 2006 Jun; 34(6):450-8.
    View in: PubMed
    Score: 0.041
  10. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Pediatr Radiol. 2005 Jan; 35(1):66-72.
    View in: PubMed
    Score: 0.037
  11. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94.
    View in: PubMed
    Score: 0.035
  12. How and by whom care is delivered influences anti-inflammatory use in asthma: Results of a national population survey. J Allergy Clin Immunol. 2003 Aug; 112(2):445-50.
    View in: PubMed
    Score: 0.034
  13. The effect of treatment of allergic rhinitis on asthma morbidity, including emergency department visits. Curr Opin Allergy Clin Immunol. 2003 Feb; 3(1):29-32.
    View in: PubMed
    Score: 0.032
  14. Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol. 2002 Jul; 110(1):58-64.
    View in: PubMed
    Score: 0.031
  15. Effects of an exercise program during pediatric stem cell transplantation: A randomized controlled trial. Pediatr Blood Cancer. 2022 05; 69(5):e29618.
    View in: PubMed
    Score: 0.030
  16. Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial. Br J Haematol. 2021 11; 195(4):612-620.
    View in: PubMed
    Score: 0.029
  17. Stoss therapy is safe for treatment of vitamin D deficiency in pediatric patients undergoing HSCT. Bone Marrow Transplant. 2021 09; 56(9):2137-2143.
    View in: PubMed
    Score: 0.029
  18. Use of inhaled anti-inflammatory medication in children with asthma in managed care settings. Arch Pediatr Adolesc Med. 2001 Apr; 155(4):501-7.
    View in: PubMed
    Score: 0.029
  19. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001 Apr; 107(4):706-11.
    View in: PubMed
    Score: 0.029
  20. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatr Radiol. 2000 Nov; 30(11):733-8.
    View in: PubMed
    Score: 0.028
  21. Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium. Pediatr Blood Cancer. 2020 11; 67(11):e28569.
    View in: PubMed
    Score: 0.027
  22. Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study. J Child Neurol. 2000 May; 15(5):344-9.
    View in: PubMed
    Score: 0.027
  23. Stroke prevention in sickle cell disease. Curr Opin Hematol. 2000 Mar; 7(2):101-5.
    View in: PubMed
    Score: 0.026
  24. Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium. Pediatr Blood Cancer. 2020 04; 67(4):e28172.
    View in: PubMed
    Score: 0.026
  25. Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era. Am J Hematol. 2019 12; 94(12):1335-1343.
    View in: PubMed
    Score: 0.026
  26. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 02; 339(1):5-11.
    View in: PubMed
    Score: 0.024
  27. Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium. Biol Blood Marrow Transplant. 2018 08; 24(8):1651-1656.
    View in: PubMed
    Score: 0.023
  28. Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition. Br J Haematol. 2018 04; 181(2):242-251.
    View in: PubMed
    Score: 0.023
  29. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998 Feb; 19(1):110-29.
    View in: PubMed
    Score: 0.023
  30. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997 Nov; 42(5):699-704.
    View in: PubMed
    Score: 0.023
  31. Vitamin D deficiency and outcomes in pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2018 Feb; 65(2).
    View in: PubMed
    Score: 0.022
  32. Needs Assessment for Patients with Sickle Cell Disease in South Carolina, 2012. Public Health Rep. 2016 Jan-Feb; 131(1):108-16.
    View in: PubMed
    Score: 0.020
  33. Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study. Lancet Haematol. 2015 Sep; 2(9):e367-75.
    View in: PubMed
    Score: 0.019
  34. Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial. Blood. 2014 Aug 07; 124(6):891-8.
    View in: PubMed
    Score: 0.018
  35. Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol. 1994 Apr; 45(4):279-82.
    View in: PubMed
    Score: 0.018
  36. Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke risk. Am J Hematol. 2014 Jan; 89(1):47-51.
    View in: PubMed
    Score: 0.017
  37. Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood. 2013 Apr 18; 121(16):3237-45.
    View in: PubMed
    Score: 0.016
  38. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke. 1992 Aug; 23(8):1073-7.
    View in: PubMed
    Score: 0.016
  39. Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia. Cytokine. 2012 Oct; 60(1):302-8.
    View in: PubMed
    Score: 0.016
  40. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells Mol Dis. 2011 Aug 15; 47(2):125-8.
    View in: PubMed
    Score: 0.015
  41. Genetic predictors for stroke in children with sickle cell anemia. Blood. 2011 Jun 16; 117(24):6681-4.
    View in: PubMed
    Score: 0.014
  42. Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease. Pediatr Blood Cancer. 2011 May; 56(5):777-82.
    View in: PubMed
    Score: 0.014
  43. Cerebral vessel stenosis in sickle cell disease: criteria for detection by transcranial Doppler. Am J Pediatr Hematol Oncol. 1990; 12(3):277-82.
    View in: PubMed
    Score: 0.013
  44. Plasma interleukin-1beta concentration is associated with stroke in sickle cell disease. Cytokine. 2010 Jan; 49(1):39-44.
    View in: PubMed
    Score: 0.013
  45. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease. Neurology. 2009 Apr 14; 72(15):1316-21.
    View in: PubMed
    Score: 0.012
  46. Obstacles to primary stroke prevention in children with sickle cell disease. Neurology. 2006 Sep 26; 67(6):1098-9.
    View in: PubMed
    Score: 0.010
  47. Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. Br J Haematol. 2006 Aug; 134(3):333-9.
    View in: PubMed
    Score: 0.010
  48. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood. 2006 Aug 01; 108(3):847-52.
    View in: PubMed
    Score: 0.010
  49. Evaluation of asthma prescription measures and health system performance based on emergency department utilization. Med Care. 2004 May; 42(5):465-71.
    View in: PubMed
    Score: 0.009
  50. Declining stroke rates in Californian children with sickle cell disease. Blood. 2004 Jul 15; 104(2):336-9.
    View in: PubMed
    Score: 0.009
  51. Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol. 2003 Aug; 25(8):622-8.
    View in: PubMed
    Score: 0.008
  52. Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen. BMC Med Genet. 2003 Jul 18; 4:6.
    View in: PubMed
    Score: 0.008
  53. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001 Dec; 139(6):785-9.
    View in: PubMed
    Score: 0.007
  54. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001 Sep; 41(9):1086-92.
    View in: PubMed
    Score: 0.007
  55. Correlation of abnormal intracranial vessel velocity, measured by transcranial Doppler ultrasonography, with abnormal conjunctival vessel velocity, measured by computer-assisted intravital microscopy, in sickle cell disease. Blood. 2001 Jun 01; 97(11):3401-4.
    View in: PubMed
    Score: 0.007
  56. Contrast sensitivity in infants and children with Down syndrome. Vision Res. 1997 Jun; 37(11):1545-55.
    View in: PubMed
    Score: 0.005
  57. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun; 126(6):896-9.
    View in: PubMed
    Score: 0.005
  58. Visual acuity in infants and children with Down syndrome. Dev Med Child Neurol. 1994 Jul; 36(7):586-93.
    View in: PubMed
    Score: 0.004
  59. Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia. J Assoc Acad Minor Phys. 1990; 1(3):79-82.
    View in: PubMed
    Score: 0.003
  60. MR and CT investigation of cerebrovascular disease in sickle cell patients. AJNR Am J Neuroradiol. 1986 Nov-Dec; 7(6):1043-9.
    View in: PubMed
    Score: 0.003
  61. Ophthalmic manifestations of the Hermansky-Pudlak syndrome (oculocutaneous albinism and hemorrhagic diathesis). Am J Ophthalmol. 1982 Jan; 93(1):71-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.